H. Lundbeck A/S/ DK0061804770 /
2024-08-28 9:59:03 PM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
7.1300USD | - | 3,400 Turnover: 24,151.5800 |
-Bid Size: - | -Ask Size: - | 7.1300 | 7.1000 |
GlobeNewswire
08-05
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
05-01
Avalyn Bolsters Leadership Team with the Appointment of Douglas Carlson as Chief Financial Officer a...
GlobeNewswire
2023-11-29
Dianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Ch...
GlobeNewswire
2022-03-28
Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2021 and Business ...
GlobeNewswire
2022-03-17
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Finan...
GlobeNewswire
2022-03-07
EyePoint Pharmaceuticals Appoints Isabelle Lefebvre as Chief Regulatory Officer
GlobeNewswire
2022-02-24
Dentsply Sirona Announces Appointment of Dr. Dorothea Wenzel as New Board Member
GlobeNewswire
2022-02-16
Mental Health America Releases First-Ever Dashboard With Results of 2.6 Million Mental Health Screen...
GlobeNewswire
2022-02-14
Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical Officer
GlobeNewswire
2021-11-02
Cellectar Appoints Laurence Reilly, M.D., LL.M Interim Chief Medical Officer
GlobeNewswire
2021-10-13
New Analysis Finds St. Louis County, Missouri Had Highest Percentage of Population Screen At-Risk fo...
GlobeNewswire
2021-08-23
Update -- Pharma Two B Appoints Jeffrey Berkowitz as Chairman of its Board of Directors
GlobeNewswire
2021-08-12
Pharma Two B Appoints Jeffrey Berkowitz as Chairman of its Board of Directors